MindMaze Therapeutics
V6M.F
#11193
Rank
A$3.02 M
Marketcap
A$0.24
Share price
-1.39%
Change (1 day)
N/A
Change (1 year)

EPS for MindMaze Therapeutics (V6M.F)

EPS in 2024: A-$2.28

According to MindMaze Therapeutics's latest financial reports the company's current EPS (TTM) is A-$2.28. In 2024 the company made an earnings per share (EPS) of A-$2.28 an increase over its 2023 EPS that were of A-$15.01.

EPS history for MindMaze Therapeutics from 2007 to 2024

Annual EPS

Year EPS Change
2024A-$2.28-84.79%
2023A-$15.0191.03%
2022A-$7.8618.81%
2021A-$6.61221.62%
2020A-$2.06-17.59%
2019A-$2.501809.94%
2018A-$0.13-78.95%
2017A-$0.62-91.95%
2016A-$7.719029.37%
2015A-$0.08447-99.45%
2014A-$15.44-68.12%
2013A-$48.42292.43%
2012A-$12.34-97.77%
2011A-$553.05192.88%
2010A-$188.831332.73%
2009A-$13.18-84.42%
2008A-$84.58956.49%
2007A-$8.01